IHC 5 Markers Biological Profile | Lahalak Platform
Comprehensive tumor characterization using 5 biomarkers covering hormonal and immune aspects, enabling physicians to develop a precise, multi-faceted treatment plan including targeted and hormonal therapies.
Scientific name: Immunohistochemistry (IHC) Interpretation and Consultation (5 Markers)
A comprehensive therapeutic consultation package is provided, based on the systematic biological characterization of the tumor using five immunohistochemical (IHC) markers selected to cover the key areas: 1) classification and diagnosis, 2) therapeutic receptors (hormonal/targeted), 3) proliferation status, 4) immune response, and 5) an additional...
Included Services
- Systematic analysis and integration of the results of five immunological markers to establish a comprehensive biological characterization of the tumor.
- Linking each symptom to available treatment options according to current clinical guidelines and data.
- Consultation on interpreting the overall results and formulating treatment recommendations with a specialized pathologist.
- Issuance of the "Comprehensive Biological Characterization Report and Treatment Map" with the Marker Table and Decision Matrix.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Identifying the five signs: A list of signs or tumor type must be provided to determine the appropriate five-signal package.
- Submit all reports: Attach all five laboratory reports in full.
- Disease stage: Clarify the stage of the disease (early, advanced, metastatic) because recommendations vary according to the stage.
- No need for new samples or fasting.
- Expected duration: 7 to 14 working days for the integrated analysis.